Craniopharyngioma laboratory tests

Craniopharyngioma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Craniopharyngioma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Treatment
Medical Therapy
Surgery
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Craniopharyngioma laboratory tests On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Craniopharyngioma laboratory tests All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Craniopharyngioma laboratory tests
CDC on Craniopharyngioma laboratory tests
Craniopharyngioma laboratory tests in the news
Blogs on Craniopharyngioma laboratory tests
Directions to Hospitals Treating Craniopharyngioma
Risk calculators and risk factors for Craniopharyngioma laboratory tests

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Patients with craniopharyngioma may have abnormal pituitary hormone levels, which is suggestive of disruption of hormone production due to pressure effects on the pituitary gland .

Laboratory Findings

• Endocrine hormone tests: Abnormal.

References

Template:WikiDoc Sources